General Information
Version
10.3
Revision date
2024-07-02
Product name
Sertraline Hydrochloride
CAS No.
79559-97-0
REACH No
is
1.2.1 Relevant identified uses
Biochemical research/analysis
Emergency telephone
+(44)-870-8200418, +(353)-19014670, 001-803-017-9114
Icons in SDS
Company Information
company name
Merck KGaA
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H373, H400, H410
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Acute toxicity, (Category 4) H302: Harmful if swallowed. Specific target organ toxicity - H373: May cause damage to organs repeated exposure, (Category 2) through prolonged or repeated exposure. Short-term (acute) aquatic H400: Very toxic to aquatic life. hazard, (Category 1) Long-term (chronic) aquatic H410: Very toxic to aquatic life with long hazard, (Category 1) lasting effects.
2.2 Label elements
Labelling
Signal word
Warning Warning
Hazard statements
H302 Harmful if swallowed. H373 May cause damage to organs through prolonged or repeated exposure. H410 Very toxic to aquatic life with long lasting effects. Reduced Labeling (<= 125 ml) none
Precautionary statements
P260 Do not breathe dust. P264 Wash skin thoroughly after handling. P273 Avoid release to the environment. P301 + P312 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. P314 Get medical advice/ attention if you feel unwell. P391 Collect spillage. none
Supplemental label elements
none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
